The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Approval of ...

NEW YORK (WABC) -- Johnson & Johnson says it will fulfill its promise to deliver 20 million doses to the federal government by the end of this month. It comes as the company is able to increase ...

NEW YORK (WABC) -- The coronavirus death toll in California has now surpassed the death toll in New York. According to Johns Hopkins, California has reported 45,496 COVID-related fatalities. New York ...

WASHINGTON -- Government advisers were split Thursday on whether drugmakers need to update their covid-19 vaccines for next season, a decision overshadowed by confusion over a new Trump administration ...

Making changes to the Centers for Disease Control recommendations is typically a lengthy and laborious process requiring evidence-based research and multiple discussions with experts and associations ...

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE (COVID-19 Vaccine, mRNA), which targets the LP.8.1 variant of SARS-CoV-2. The data ...

CHICAGO (WLS) -- Gov. JB Pritzker set out his plan Monday to get 1.1 million children in Illinois vaccinated against COVID-19. Illinois and Chicago are making plans to get shots into arms as quickly ...

"It's of course very aggressive -- but it is possible," a scientist says. With top White House officials indicating a coronavirus vaccine may be available by January 2021, scientists and vaccine ...

As vaccine-makers reroute their COVID-19 therapy and vaccine plans for the future of the pandemic, drugmakers are testing potential avenues with human proteins and intranasal options. 1. Researchers ...